Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$514.7K
66.67K shares
What this filing means
HECHT BETH plans to sell 66.67K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $514.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2025ACC: 0001950047-25-008678
Officer· See Remarks
Since Oct 2021
66.67K
Shares to sell
$514.7K
Approx. market value
66.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/14/2019
66.67KTotal acquired66.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2019 | Restricted Stock Units N/A | 66.67K | — |
| Total | 66.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
66.67K
Market value
$514.7K
11/11/2025
Total
Units
66.67K
Value
$514.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/11/2025 | 66.67K | $514.7K | NASDAQ | Planned |
| Total | 66.67K | $514.7K | ||